Showing 1 - 1 results of 1 for search '"Michael Durant"', query time: 0.98s Refine Results
  1. 1
    703 Single cell analysis of phase II study of nivolumab and relatlimab in metastatic uveal melanoma reveals tumor and immune response to dual PD-1 and LAG-3 inhibition

    703 Single cell analysis of phase II study of nivolumab and relatlimab in metastatic uveal melanoma reveals tumor and immune response to dual PD-1 and LAG-3 inhibition by Jose Lutzky, Anthony Cruz, Satu Mustjoki, James Dollar, Christina Decatur, Michael Durante, Jani Huuhtanen, Zelia Correa, J William Harbour

    Published 2023-11-01
    Article

Search Tools: